Abstract Details

Title A Case of Severe Legionella Pneumonia following the Second Treatment Course of Alemtuzumab Infusion for Relapsing Remitting Multiple Sclerosis

Topic Multiple Sclerosis

Presentation(s) P5 - (-)

Poster/Presentation
Number 352

Background

Objective

Design/Methods

Results

Conclusions

Authors/Disclosures
Elizabeth Spurgeon, MD (Cleveland Clinic Foundation) PRESENTER	Dr. Spurgeon has nothing to disclose.
Justin Abbatemarco, MD (Cleveland Clinic Foundation)	Dr. Abbatemarco has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Abbatemarco has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Abbatemarco has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech . Dr. Abbatemarco has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics, Inc.. The institution of Dr. Abbatemarco has received research support from Horizon.
Mary R. Rensel, MD, FAAN	Dr. Rensel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Rensel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cycle Pharma. Dr. Rensel has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biogen. Dr. Rensel has stock in Brain Fresh LLC . The institution of Dr. Rensel has received research support from NMSS. The institution of Dr. Rensel has received research support from Roche- Genentech .